Graft-versus-Host Disease Modulation by Innate T Cells

Allogeneic cell therapies, defined by genetically mismatched transplantation, have the potential to become a cost-effective solution for cell-based cancer immunotherapy. However, this type of therapy is often accompanied by the development of graft-versus-host disease (GvHD), induced by the mismatch...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Ying, Zhu, Yichen, Kramer, Adam, Chen, Yuning, Li, Yan-Ruide, Yang, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962599/
https://www.ncbi.nlm.nih.gov/pubmed/36835495
http://dx.doi.org/10.3390/ijms24044084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962599/
https://www.ncbi.nlm.nih.gov/pubmed/36835495
http://dx.doi.org/10.3390/ijms24044084

Ejemplares similares